Gerstein Fisher’s Elevance Health ELV Stock Holding History

Gerstein Fisher’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$4.37M	Buy	34,851 +7,870	+29%	+$1.02M	0.54%	31
2016 Q2	$3.54M	Sell	26,981 -519	-2%	-$71K	0.46%	35
2016 Q1	$3.82M	Hold	27,500	–	–	0.52%	32
2015 Q4	$3.83M	Sell	27,500 -27	-0.1%	-$3.72K	0.53%	28
2015 Q3	$3.85M	Buy	27,527 +18,094	+192%	+$2.72M	0.58%	24
2015 Q2	$1.55M	Buy	9,433 +594	+7%	+$94.9K	0.25%	91
2015 Q1	$1.36M	Buy	8,839 +463	+6%	+$65.9K	0.23%	96
2014 Q4	$1.05M	Buy	8,376 +87	+1%	+$10.8K	0.17%	123
2014 Q3	$992K	Buy	8,289 +631	+8%	+$72.4K	0.17%	118
2014 Q2	$824K	Buy	7,658 +158	+2%	+$16.3K	0.16%	119
2014 Q1	$747K	Sell	7,500 -7,264	-49%	-$657K	0.15%	122
2013 Q4	$5.74M	Buy	14,764 +7,516	+104%	+$668K	0.21%	120
2013 Q3	$606K	Buy	7,248 +89	+1%	+$7.63K	0.13%	145
2013 Q2	$586K	Buy	+7,159	New	+$536K	0.14%	133

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Gerstein Fisher's ELV Position: Q3 2016 in Review

Gerstein Fisher increased its Elevance Health (ELV) stake by 29% in Q3 2016, buying an estimated $1.02M and bringing the position to 34,851 shares worth $4.37M. The position accounts for 0.54% of the portfolio, ranked #31.

Gerstein Fisher first reported a position in ELV in Q2 2013 and has held it in 14 quarters since. The position peaked at $5.74M in Q4 2013. 735 funds tracked by Wall St. Rank hold ELV as of Q3 2016.

Gerstein Fisher held 34,851 shares of Elevance Health worth $4.37M as of Q3 2016.
Gerstein Fisher bought 7,870 Elevance Health shares in Q3 2016, an estimated $1.02M.
Elevance Health made up 0.54% of Gerstein Fisher's portfolio in Q3 2016, its #31 holding.
Gerstein Fisher first reported a position in Elevance Health in Q2 2013 and has held it in 14 quarters since.
Gerstein Fisher's Elevance Health position peaked at $5.74M in Q4 2013.
735 funds tracked by Wall St. Rank held Elevance Health as of Q3 2016.

Based on Gerstein Fisher's 13F filing for Q3 2016, filed 15 Nov 2016.